跳至主要内容
临床试验/NCT07842406
NCT07842406尚未招募不适用

A Retrospective, Multi-center, Observational, Post-marketing Surveillance Study to Obtain Clinical Outcome Data on the Eurosilicone IVTE Range of Silicone Breast Expanders When Used for Breast Reconstruction.

GCA (Eurosilicone)0 个研究点目标入组 100 人开始时间: 2026年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100
主要终点
Rate of reconstruction failure

研究概览

简要总结

Patients can undergo breast reconstruction surgery in two stages before implantation of the permanent prosthesis for several reasons. In order to confidently state safety and due to strict regulation on medical devices it is important to maintain a record of safety and performance with all medical implants.

This study is designed to collect data on Integrated valve tissue expander to assess the performance and safety data on this device.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •• Subjects aged ≥18
  • •Subjects who underwent single or bilateral breast implantation with the study device for one of the following reasons:
  • •Reconstruction of the breast following subcutaneous mastectomy and other mastectomy procedures or trauma.
  • •Breast underdevelopment and combined breast and chest wall abnormalities.
  • •Scar/defect revision
  • •Subjects who have received a Eurosilicone IVTE.

排除标准

  • •Subjects with contra-indication to the surgery or not filling Instruction for Use (IFU) indications, contra-indications.

结局指标

主要结局

Rate of reconstruction failure

时间窗: 2 years after the tissue expander implantation surgery

Reconstruction failure means that the definitive reconstructive surgery (breast implant or autologous reconstruction) either did not take place or was unsuccessful.

次要结局

未报告次要终点

研究者

发起方
GCA (Eurosilicone)
申办方类型
Industry
责任方
Sponsor

相似试验